OC
ZBH icon

Oarsman Capital’s Zimmer Biomet ZBH Stock Holding History

Oarsman Capital’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,360
Closed -$212K – 260
2025
Q4 		$212K Sell
2,360
-70
-3% -$6.64K 0.03% 224
2025
Q3 		$239K Sell
2,430
-623
-20% -$61.7K 0.03% 216
2025
Q2 		$278K Buy
3,053
+1,042
+52% +$101K 0.04% 195
2025
Q1 		$228K Sell
2,011
-50
-2% -$5.35K 0.04% 208
2024
Q4 		$218K Hold
2,061
– – 0.04% 216
2024
Q3 		$222K Buy
+2,061
New +$225K 0.04% 222

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Oarsman Capital's ZBH Position: Q1 2026 in Review

Oarsman Capital sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 2,360 shares — an estimated $212K sold.

Oarsman Capital first reported a position in ZBH in Q3 2024 and held it in 6 quarters. The position peaked at $278K in Q2 2025. 916 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Oarsman Capital reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
  • Oarsman Capital sold 2,360 Zimmer Biomet shares in Q1 2026, an estimated $212K.
  • Oarsman Capital first reported a position in Zimmer Biomet in Q3 2024 and held it in 6 quarters.
  • Oarsman Capital's Zimmer Biomet position peaked at $278K in Q2 2025.
  • 916 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Oarsman Capital's 13F filing for Q1 2026, filed 28 Apr 2026.